Eyevensys
Platforms for long acting non-viral gene therapy for ocular diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
€136m (Public information from Aug 2021)
Company register number 509397832
Paris Île-de-France (HQ)
Authorizing premium user...